Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The role of nitric oxide (NO) in the genesis of cerebral malaria is controversial. Most investigators propose that the unfortunate consequence of the high concentrations of NO produced to kill the parasite is the development of cerebral malaria. Here we have tested this high NO bioavailability hypothesis in the setting of experimental cerebral malaria (ECM), but find instead that low NO bioavailability contributes to the genesis of ECM. Specifically, mice deficient in vascular NO synthase showed parasitemia and mortality similar to that observed in control mice. Exogenous NO did not affect parasitemia but provided marked protection against ECM; in fact, mice treated with exogenous NO were clinically indistinguishable from uninfected mice at a stage when control infected mice were moribund. Administration of exogenous NO restored NO-mediated signaling in the brain, decreased proinflammatory biomarkers in the blood, and markedly reduced vascular leak and petechial hemorrhage into the brain. Low NO bioavailability in the vasculature during ECM was caused in part by an increase in NO-scavenging free hemoglobin in the blood, by hypoargininemia, and by low blood and erythrocyte nitrite concentrations. Exogenous NO inactivated NO-scavenging free hemoglobin in the plasma and restored nitrite to concentrations observed in uninfected mice. We therefore conclude that low rather than high NO bioavailability contributes to the genesis of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was suggested to contribute to the pathogenesis of severe forms of malaria in mice, without interfering with host pathogen burden [192], thus arguing that NO scavenging by extracellular hemoglobin impairs disease tolerance to Plasmodium infection.”
From The Iron age of host–microbe interactions (2015) · cites this paper as [192]
In the citing paper
“The mechanisms underlying the pathogenic effects of extracellular hemoglobin were associated originally to NO scavenging, reducing NO bioavailability, and impairing microvascular homeostasis [192,196] (Fig 4).”
From The Iron age of host–microbe interactions (2015) · cites this paper as [192]
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“Thus, we posit that low NO bioavailability exacerbates underlying pathogenic processes, as observed in sickle cell diseas”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
Stevenson, M. M., & Riley, E. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1311 · Cited by 653
Anstey, N. M., Weinberg, J. B., Hassanali, M. Y., Mwaikambo, E. D., Manyenga, D., Misukonis, M. A., Arnelle, D. R., Hollis, D., McDonald, M. I., & Granger, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.557 · Cited by 431
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
Wagener, F. A. D. T. G., Eggert, A., Boerman, O. C., Oyen, W. J. G., Verhofstad, A., Abraham, N. G., Adema, G., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Blood · doi:10.1182/blood.v98.6.1802 · Cited by 421
[26] Oxidative reactions of hemoglobin
Winterbourn, C. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86118-f · Cited by 409
van der Heyde, H. C., Nolan, J., Combes, V., Gramaglia, I., & Grau, G. E. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.002 · Cited by 400
Self-citation
Cited by
Items 101–200 of 215
Brant, F., de Miranda, A. S., Esper, L., Gualdrón‐López, M., Cisalpino, D., de Souza, D. D. G., Rachid, M. A., Tanowitz, H. B., Teixeira, M. M., Teixeira, A. L., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.01.002 · Cited by 28
“During malaria infection, the low bioavailability of NO has been associated with CM pathogenesis (Gramaglia et al., 2006), and previous studies have indicated that the administration of NO might suppress the development of CM (Cabrales et al.”
Heme moves to center stage in cerebral malaria
Hunt, N. H., & Stocker, R. (2007) · Nature Medicine · doi:10.1038/nm0607-667 · Cited by 33
Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes
Levesque, M. C., Hobbs, M. R., O’Loughlin, C. W., Chancellor, J. A., Chen, Y., Tkachuk, A. N., Booth, J., Patch, K. B., Allgood, S. D., Pole, A. R., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0753-3 · Cited by 28
“In this mouse model and in recent reports from studies in human subjects, NO appears to be protective in malaria because of its effects in maintaining endothelial function and microvascular perfusion, preventing endothelial activation, reducing red blood cell—endothelial cell adhesion and ameliorating deleterious cyto…”
BackgroundNitric oxide for the adjunctive treatment of severe malaria: Hypothesis and rationale
Hawkes, M., Opoka, R. O., Namasopo, S., Miller, C., Conroy, A. L., Serghides, L., Kim, H., Thampi, N., Liles, W. C., John, C. C., et al. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.003 · Cited by 27
“Severe malaria syndromes are characterized by low nitric oxide bioavailability In an animal model, reduced NO bioavailability contributed to the pathogenesis of ECM [4].”
BackgroundMethodInfluentialA new hypothesis on the manifestation of cerebral malaria: The secret is in the liver
Martins, Y. C., & Daniel‐Ribeiro, C. T. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.005 · Cited by 29
“High levels of hemoglobin released in the plasma following parasite replication in RBCs leads to the generation of free heme, a toxic metabolite which scavenges nitric oxide (NO), causing endothelial disturbances and damage to the BBB [31,33,34].”
InfluentialRey, J., Buffet, P. A., Cicéron, L., Milon, G., Mercereau‐Puijalon, O., & Safeukui, I. (2014) · Scientific Reports · doi:10.1038/srep03767 · Cited by 26
Duan, H., Zhao, S., Xiang, J., Ju, C., Chen, X., Gramaglia, I., & Yan, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00582-8 · Cited by 26
Self-citationLow serum total nitrite and nitrate levels in severe leptospirosis
Kalugalage, T. L., Rodrigo, C., Vithanage, T. D. P., Somaratne, P., de Silva, H. J., Handunnetti, S. M., & Rajapakse, S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-206 · Cited by 26
“[26] demonstrated that low NO bioavailability contributes to the genesis of experimental cerebral malaria.”
BackgroundRoles and current applications of S-nitrosoglutathione in anti-infective biomaterials
Hu, Q., Ye, Z., Pi, L., & Ao, J. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100419 · Cited by 34
Martins, Y. C., Clemmer, L., Orjuela-Sánchez, P., Zaniní, G. M., Ong, P. K., Frangos, J. A., & Carvalho, L. J. M. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-138 · Cited by 25
Self-citationAngiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice
Gallego‐Delgado, J., Baravian, C., Edagha, I. A., Ty, M., Ruiz‐Ortega, M., Xu, W., & Rodríguez, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138191 · Cited by 24
“berghei infection, on one side inhibiting parasite growth as observed in vitro in this study and others [8, 11], on the another side facilitating protective immune or other mechanisms that affect the pathogenesis of experimental cerebral malaria [17], or even by acting on cardiovascular function by restoring blood pre…”
BackgroundMoreira, A. D. S., Estato, V., Malvar, D. D. C., Sanches, G. S., Gomes, F., Tibiriçá, E. V., Daniel‐Ribeiro, C. T., & Carvalho, L. J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49855-x · Cited by 25
Wang, Q., Liu, Y., Liu, J., Chen, G., Zheng, W., Wang, J., & Cao, Y. (2008) · Experimental Parasitology · doi:10.1016/j.exppara.2008.11.013 · Cited by 24
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria
Bertinaria, M., Orjuela-Sánchez, P., Marini, E., Guglielmo, S., Hofer, A., Martins, Y. C., Zaniní, G. M., Frangos, J. A., Gasco, A., Fruttero, R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01036 · Cited by 23
“1-Bromo-2-(10b-dihydroartemisinoxy)ethane (5) was treated with methylamine (33% in absolute ethanol) to give the substitution product 6.”
MethodSelf-citationChertow, J. H., Alkaitis, M. S., Nardone, G. A., Ikeda, A. K., Cunnington, A. J., Okebe, J., Ebonyi, A. O., Njie, M., Correa, S., Jayasooriya, S., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005119 · Cited by 22
“In a mouse model, treatment with an NO-donor improved cerebral microcirculation, reduced cerebral hemorrhages and prevented blood-brain barrier break-down [6,7].”
BackgroundDhangadamajhi, G., Mohapatra, B. N., Kar, S. K., & Ranjit, M. (2009) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2009.06.010 · Cited by 22
Helegbe, G. K., Yanagi, T., Senba, M., Huy, N. T., Shuaibu, M. N., Yamazaki, A., Kikuchi, M., Yasunami, M., & Hirayama, K. (2010) · Parasitology Research · doi:10.1007/s00436-010-2121-6 · Cited by 22
“This is consistent with other studies where a higher level of parasitemia results in higher amounts of free hemoglobin leading to free heme released (Gramaglia et al. 2006; Pamplona et al. 2007; Penet et al. 2006).”
ResultArtesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria
Du, Y., Chen, G., Zhang, X., Yu, C., Cao, Y., & Cui, L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.008 · Cited by 23
Mechanisms and Clinical Complications of Hemolysis in Sickle Cell Disease and Thalassemia
Kato, G. J., & Gladwin, M. T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.016 · Cited by 28
Oral administration of vitamin D and importance in prevention of cerebral malaria
Wu, B., Du, Y., Feng, Y., Wang, Q., Pang, W., Qi, Z., Wang, J., Yang, D., Liu, Y., & Cao, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.041 · Cited by 22
Henrici, R. C., Sautter, C., Bond, C., Opoka, R. O., Namazzi, R., Datta, D., Ware, R. E., Conroy, A. L., & John, C. C. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004704 · Cited by 24
“Children with SCA in this study also had increased Angpt-2 and a low L-arginine/ADMA ratio, which have been previously associated with disease severity and risk of complications, includingmortality, in adults and children.(20,46,47,73-75) In our cohort, lower levels of TNF-a were associated with increased risk of all-…”
BackgroundDynamic interactions ofPlasmodiumspp. with vascular endothelium
Gillrie, M. R., & Ho, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1268667 · Cited by 26
Orjuela-Sánchez, P., Ong, P. K., Zaniní, G. M., Melchior, B., Martins, Y. C., Meays, D. R., Frangos, J. A., & Carvalho, L. J. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00488-13 · Cited by 20
“Therefore, providing exogenous NO during PbA infection may prevent the very causes of iNOS and eNOS upregulation, decreasing inflammation and ameliorating endothelial function in ECM (22, 24, 25).”
BackgroundResultInfluentialSelf-citationPlatelets in pulmonary hypertension: a causative role or a simple association?
Zanjani, K. S. (2012) · PubMed · Cited by 27
Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei
Torre, S., Langlais, D., & Gros, P. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9752-9 · Cited by 23
Nitric Oxide in Post-cardiac Arrest Syndrome
Miyazaki, Y., & Ichinose, F. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000765 · Cited by 22
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
Ong, P. K., Moreira, A. D. S., Daniel‐Ribeiro, C. T., Frangos, J. A., & Carvalho, L. J. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-34249-2 · Cited by 20
Self-citationLwanira, C. N., Kironde, F., Kaddumukasa, M., & Swedberg, G. (2017) · Malaria Journal · doi:10.1186/s12936-017-1970-1 · Cited by 21
Nitric oxide in parasitic infections: a friend or foe?
Omar, M., & Abdelal, H. O. (2022) · Journal of Parasitic Diseases · doi:10.1007/s12639-022-01518-x · Cited by 22
“Several reports have supported the protective role of this compound in cerebral malaria (Cabrales et al. 2011; Gramaglia et al. 2006).”
BackgroundKenchegowda, D., Legesse, B., Hritzo, B. A., Olsen, C. H., Aghdam, S. Y., Kaur, A., Culp, W. E., Derrien-Colemyn, A., Severson, G., & Moroni, M. (2018) · Radiation Research · doi:10.1667/rr14993.1 · Cited by 19
“An association between decreased NO signaling and bleeding has been demonstrated in the brain of a mouse model of experimental malaria, where administration of NO donors restored NO signaling and reduced vascular leakage and petechiae (40).”
CD19(+) B Cells Confer Protection against Experimental Cerebral Malaria in Semi-Immune Rodent Model
Lam, B., Huy, N. T., Kikuchi, M., Yanagi, T., Senba, M., Shuaibu, M. N., Honma, K., Yui, K., & Hirayama, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064836 · Cited by 21
“immunity and malaria parasite mediated immunopathology [32,33].”
Inhaled Nitric Oxide and Cerebral Malaria: Basis of a Strategy for Buying Time for Pharmacotherapy
Bergmark, B. A., Bergmark, R. W., Beaudrap, P. D., Boum, Y., Mwanga‐Amumpaire, J., Carroll, R. W., & Zapol, W. M. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318266c113 · Cited by 21
“Mice deficient in NOS2 or NOS3 have equivalent courses of CM as do controls when infected with Plasmodium berghei ANKA, and delivery of an exogenous NO donor to NOS-deficient mice prevents CM and reduces the inflammatory response.(33) Similarly, CM has been reported in a NOS2-deficient murine model with pharmaceutical…”
BackgroundNitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism
Planche, T., Macallan, D. C., Sobande, T. O., Borrmann, S., Kun, J. F. J., Krishna, S., & Kremsner, P. G. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00390.2010 · Cited by 18
Borges, T. K. S., Alves, É., Vasconcelos, H., Carneiro, F., Nicola, A., Magalhães, K., & Muniz-Junqueira, M. (2017) · Immunobiology · doi:10.1016/j.imbio.2016.11.010 · Cited by 16
Khandare, A. V., Bobade, D., Deval, M., Patil, T., Saha, B., & Prakash, D. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.04.025 · Cited by 18
Antioxidant therapy: Reducing malaria severity?*
Ackerman, H. C., Beaudry, S. D., & Fairhurst, R. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e318194d5de · Cited by 20
“Microcirculatory dysfunction may be worsened as nitric oxide is scavenged by cell-free hemoglobin released during hemolysis and by reactive oxygen species (7).”
BackgroundCorbett, Y., D’Alessandro, S., Parapini, S., Scaccabarozzi, D., Kalantari, P., Zava, S., Giavarini, F., Caruso, D., Colombo, I., Egan, T. J., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2602-0 · Cited by 16
“How the bioavailability of NO contributes to the status of severe malaria is still controversial [11, 13].”
BackgroundHeme oxygenase-1, carbon monoxide, and malaria – The interplay of chemistry and biology
Pena, A. C., & Pamplona, A. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214285 · Cited by 18
Conroy, A. L., Datta, D., Opoka, R. O., Batte, A., Bangirana, P., Gopinadhan, A., Mellencamp, K. A., Akcan‐Arikan, A., Idro, R., & John, C. C. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1177242 · Cited by 15
“Reduced nitric oxide bioavailability is well described in severe malaria (Anstey et al., 1996; Hobbs et al., 2002; Lopansri et al., 2003; Gramaglia et al., 2006; Yeo et al., 2007, 2010).”
BackgroundGramaglia, I., Velez, J., Chang, Y., Caparrós‐Wanderley, W., Combes, V., Grau, G. E., Stins, M. F., & van der Heyde, H. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213428 · Cited by 15
Self-citationAdewole, K. E., & Adebayo, J. O. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60354-6 · Cited by 15
Varela, E. L. P., Gomes, A. R. Q., dos Santos, A. D. S. B., de Carvalho, E., Vale, V. V., & Percário, S. (2022) · Nutrients · doi:10.3390/nu14245303 · Cited by 20
“Experimental evidence indicates that NO plays an important role in the defense against plasmodia in vitro and in vivo [136,137].”
Elphinstone, R. E., Besla, R., Shikatani, E. A., Lu, Z., Hausladen, A., Davies, M., Robbins, C. S., Husain, M., Stamler, J. S., & Kain, K. C. (2017) · Infection and Immunity · doi:10.1128/iai.00371-17 · Cited by 15
“Various attempts to improve NO bioavailability have included the use of L-arginine, a precursor for NO synthesis (16), and inhaled NO (23, 24).”
Gao, R., Wang, L., Li, D., Song, J., Li, Q., Jiang, L., Li, L., Li, Y., Ye, T., Wang, J., et al. (2024) · Science China Materials · doi:10.1007/s40843-024-2808-2 · Cited by 15
“While low concentrations of NO contributes to the occurrence of nerve disease [8].”
Luckhart, S., Lieber, M. J., Singh, N. P., Zamora, R., & Yoram Vodovotz, B. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.08.013 · Cited by 13
“, 2002) and in mice (Gramaglia et al., 2006) were associated with less severe malaria but no differences in parasitemia levels.”
BackgroundResultPlasmodium falciparum: Nitric oxide modulates heme speciation in isolated food vacuoles
Ostera, G. R., Tokumasu, F., Teixeira, C., Collin, N., Sá, J. M., Hume, J. C. C., Kumar, S., Ribeiro, J. M. C., Lukat-Rodgers, G. S., & Rodgers, K. R. (2010) · Experimental Parasitology · doi:10.1016/j.exppara.2010.05.006 · Cited by 13
Basilico, N., Parapini, S., Sisto, F., Omodeo‐Salè, F., Coghi, P. S., Ravagnani, F., Olliaro, P., & Taramelli, D. (2010) · BioMed Research International · doi:10.1155/2010/854927 · Cited by 13
“As feed back effect, the endothelial cells will augment the production of nitric oxide (NO) which is reported to have beneficial effects in murine cerebral malaria [42].”
BackgroundDellaValle, B., Staalsøe, T., Kurtzhals, J. A. L., & Hempel, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059271 · Cited by 13
“Interestingly, NO and CO have been shown to be protective in murine models of CM [16,17].”
BackgroundOliveira, K. R. H. M., Kauffmann, N., Leão, L. K. R., Passos, A. D. C. F., Rocha, F. A. D. F., Herculano, A. M., & do Nascimento, J. L. M. (2017) · Malaria Journal · doi:10.1186/s12936-017-2083-6 · Cited by 12
“Also, previous reports have suggested that nitric oxide (NO), a product of the nitric oxide synthase enzymes (NOS), may also contribute to the pathogenesis of CM but its mechanism of action during the disease is controversial [60, 61].”
BackgroundMiscellanea on Encephalopathies
Legname, G., & Zanusso, G. (2012) · InTech eBooks · doi:10.5772/1191 · Cited by 11
Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria
Kayano, A. C. A. V., Dos-Santos, J. C., Bastos, M. F., Carvalho, L. J. M., Aliberti, J., & Costa, F. T. M. (2016) · Infection and Immunity · doi:10.1128/iai.01404-15 · Cited by 11
“Reduced NO bioavailability has been reported in human malaria (59) and ECM (33), and this phenomenon could contribute to the development of disease by impairment of endothelial function and vascular perfusion, as reviewed elsewhere (60).”
BackgroundDas, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_3 · Cited by 12
Different regulatory mechanisms in protozoan parasitic infections
Kling, J. C., & Körner, H. (2013) · International Journal for Parasitology · doi:10.1016/j.ijpara.2013.02.001 · Cited by 15
“However, low levels of NO correlate with experimental cerebral malaria, suggesting that NO may prevent the immunopathology associated with malaria, rather than affecting parasitaemia (Gramaglia et al., 2006).”
BackgroundExperimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria.
El‐Assaad, F., Combes, V., & Grau, G. E. (2014) · PubMed · Cited by 11
Oliveira‐Lima, O. C., Bernardes, D., Pinto, M. C. X., Arantes, R. M. E., & Tavares, J. C. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.08.001 · Cited by 10
“berghei ANKA, in which NO donor (dipropylenetriamine NONOate) treatment decreased the number of adherent leukocytes and platelets in cerebral pial vessels and provided protection against the disease [15,16,25].”
BackgroundResultAriani, A., Anjani, G., Sofro, M. A. U., & Djamiatun, K. (2018) · Jurnal Gizi Indonesia (The Indonesian Journal of Nutrition) · doi:10.14710/jgi.6.2.131-138 · Cited by 10
Molecular targets in cerebral malaria for developing novel therapeutic strategies
Ravisankar, V., Nakka, V. P., Simhadri, P. K., Baruah, U. K., & Babu, P. P. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.01.020 · Cited by 11
Severe Malaria Increases the List of Heme Oxygenase-1-Protected diseases
Pamplona, A., Clark, I. A., & Mota, M. M. (2007) · Future Microbiology · doi:10.2217/17460913.2.4.361 · Cited by 10
“Interestingly, NO, which induces HO-1 [9,10], was also shown to protect mice from ECM [11].”
BackgroundA moonlighting job for α-globin in blood vessels
Abbineni, P. S., Baid, S., & Weiss, M. J. (2024) · Blood · doi:10.1182/blood.2023022192 · Cited by 10
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
Serghides, L. (2011) · PPAR Research · doi:10.1155/2012/513865 · Cited by 9
“[141] I.”
BackgroundMorris, C. R. (2010) · The Open Nitric Oxide Journal · doi:10.2174/1875042701002020041 · Cited by 10
“It is also of interest to note that lowest plasma arginine concentration is associated with severity of malaria, another hemolytic disorder in which the degree of hypoargininaemia was significantly associated with parasite burden, degree of endothelial dysfunction and cerebral malaria case-fatality in children [37-39].”
BackgroundNyariki, J. N., Kimani, N. M., Kibet, P. S., Kinuthia, G. K., & Isaac, A. O. (2023) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2023.111579 · Cited by 11
Oxidative and nitrosative stresses in cerebral malaria: can we target them to avoid a bad prognosis?
Pereira, D. M. S., Carvalho, A. R., Lacerda, E. M. D. C. B., da Silva, L. C. N., Marinho, C. R. F., Andrè, E., & Fernandes, E. S. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa032 · Cited by 11
Baindara, P., Agrawal, S., & Franco, O. L. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2044794 · Cited by 9
Normark, J., Nelson, M., Engström, P., Andersson, M., Björk, R., Möritz, T., Fahlgren, A., & Bergström, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103295 · Cited by 7
“L-Arginine is a key amino acid in several metabolic pathways including synthesis of NO, and is considered of main importance during severe malaria [20].”
BackgroundConroy, A. L., Hawkes, M., Hayford, K. T., Hermann, L. L., McDonald, C. R., Sharma, S., Namasopo, S., Opoka, R. O., John, C. C., Liles, W. C., et al. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0719-2 · Cited by 8
“Preclinical data from an experimental model of cerebral malaria (CM) reported improved survival, reduced systemic inflammation and endothelial activation, and retained blood-brain-barrier integrity following administration of iNO [9, 10].”
BackgroundDexamethasone increased the survival rate in Plasmodium berghei-infected mice
Moreira, D. R., Uberti, A. C. M. G., Gomes, A. R. Q., Ferreira, M. E. S., Barbosa, A. D. S., Varela, E. L. P., Dolabela, M. F., & Percário, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82032-7 · Cited by 8
Thinking outside the cell: how cell-free hemoglobin can potentiate acute lung injury
Bastarache, J. A., Roberts, L. J., & Ware, L. B. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2013 · Cited by 8
“It is well accepted that intravascular cell-free hemoglobin is important in the pathogenesis of several diseases, including pulmonary hypertension associated with sickle cell disease (17), adverse reactions to red blood cell transfusions (3), and cerebral malaria (9), and as a disease modifier in atherosclerosis (14).”
BackgroundBrooks, S., Ruhl, A. P., Zeng, X., Cruz, P., Hassan, S. A., Kamenyeva, O., Hakim, M. A., Ridley, L. A., Nagata, B. M., Kabát, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066003 · Cited by 8
“…similar; however, the arterial wall puncta were distinguishable from RBC and RBC clusters based on their smaller size (median [25th, 75th]: 16 [7, 30] versus 212 [109, 320] μm 3 ; P <0.0001) and greater intensity (107 [96, 118] versus 34 [33, 36] arbitrary brightness units; P <0.0001; Figure S1).”
InfluentialOng, P. K., Meays, D. R., Frangos, J. A., & Carvalho, L. J. M. (2012) · Microcirculation · doi:10.1111/micc.12034 · Cited by 6
“This suggested that smooth muscle activity was still intact to some extent in ECM, but pathological events independent of eNOS (e.g., NO quenching by cell-free hemoglobin and reactive oxygen species [10,37]) may play a role in the mitigation of NO-elicited cerebroarteriolar dilation.”
BackgroundSelf-citationDellaValle, B., Hempel, C., Staalsøe, T., Johansen, F. F., & Kurtzhals, J. A. L. (2016) · Malaria Journal · doi:10.1186/s12936-016-1486-0 · Cited by 7
“This may also contribute to the lack of effect of liraglutide in ECM, where nitric oxide is a known protective agent [20].”
BackgroundTRPV1 Contributes to Cerebral Malaria Severity and Mortality by Regulating Brain Inflammation
Pereira, D. M. S., Teixeira, S. A., Murillo, O. J., Peixoto, E. P. M., Araújo, M. C., Sousa, N. C. F., Monteiro‐Neto, V., Calixto, J. Β., Cunha, T. M., Marinho, C. R. F., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9451671 · Cited by 6
“Several mechanisms were found to contribute to cerebral malaria including alterations in nitric oxide availability, unbalanced oxidative stress responses, changes in the pattern of expression of in fl ammatory molecules, vascular leakage, and blood brain barrier disruption, amongst others [4 – 10].”
Gul, S., Ackerman, H. C., Daniel‐Ribeiro, C. T., & Carvalho, L. J. M. (2022) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760220184 · Cited by 7
“Accepted 06 December 2022 arginine, and proinflammatory cytokines.(6-12) Recently, a multicenter study in Africa showed that among children hospitalized with severe Plasmodium falciparum malaria complicated by impaired consciousness or severe acidosis, whole blood transfusion was associated with increased survival.”
BackgroundCarpinter, B. A., Renhe, D. C., Bellei, J. C. B., Vieira, C. D., Rodolphi, C. M., Rangel-Ferreira, M. V., de Freitas, C. S., Neto, A. F. D. S., Coelho, E. A. F., Mietto, B. S., et al. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109492 · Cited by 8
Liu, T., Zhu, F., Tan, N., Chen, S., & Xu, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00012-5 · Cited by 6
Zheng, Z., Liu, H., Wang, X., Zhang, Y., Qu, S., Yang, Y., Deng, S., Chen, L., Zhu, X., & Li, Y. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00085 · Cited by 6
Hassan, D. A., Marques, C., Santos-Gomes, G. M., do Rosário, V. E., Mohamed, H. S., Elhussein, A. M., Ibrahim, M. E., & Abdulhadi, N. H. (2009) · Annals of Tropical Medicine and Parasitology · doi:10.1179/136485909x435049 · Cited by 6
“It is anti-inflammatory and beneficial to host survival in many animal models of infection, including rodent malaria (Gramaglia et al., 2006).”
BackgroundTacrolimus prevents murine cerebral malaria
Lam, B., Nhi, D. M., Huy, N. T., Hamano, S., & Hirayama, K. (2016) · Immunology · doi:10.1111/imm.12661 · Cited by 4
Experimental malaria : the in vitro and in vivo blood pressure paradox
Nwokocha, C. R., Nwokocha, M., Owu, D. U., Ajayi, I. O., & Ebeigbe, A. B. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2011-059 · Cited by 4
Die Bedeutung der Hämolyse in Anästhesie und Intensivmedizin
Graw, J. A., Baron, D. M., & Francis, R. C. E. (2018) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-0043-121622 · Cited by 7
“Auch wenn dies in Einzelfällen suffizient gelang, so beschränkt sich die aktuelle Evidenz auf einige wenige Fallberichte und ‑serien [74,75].”
BackgroundInfluentialInhaled Nitric Oxide—Current Practice and Future Potential Uses and Development
Ichinose, F., & Zapol, W. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00025-9 · Cited by 4
Severe Hemolysis as a Potential Contributing Factor in the Pathophysiology of Cerebral Malaria
Eisenhut, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1149 · Cited by 4
Varela, E. L. P., Gomes, A. R. Q., Barbosa, A. D. S., Guimarães, M. D. S., de Carvalho, E. P., Ferreira, O. O., de Oliveira, M. S., Iriti, M., Andrade, E. H. D. A., & Percário, S. (2025) · Parasite Immunology · doi:10.1111/pim.70019 · Cited by 2
Moreira, D. R., Uberti, A. C. M. G., Gomes, A. R. Q., Ferreira, M. E. S., Santos, R. S., Green, M. D., Vieira, J. R. D. S., Dolabela, M. F., & Percário, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/497966 · Cited by 4
PATHOPHYSIOLOGY OF HEMOGLOBIN AND ITS DISORDERS
Steinberg, M. H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.012 · Cited by 3
Yang, J., Han, X., Gao, K.-N., & Qi, Z. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00623 · Cited by 2
Al, F. D., Engin, A. B., Bukan, N. C., Evirgen-Bostanci, S., & Çeber, K. (2015) · Pteridines · doi:10.1515/pterid-2014-0019 · Cited by 2
“[38] indicated that exogenously given NO inactivates NO-scavenging free hemoglobin in the plasma and restores nitrite to the concentrations observed in uninfected mice; therefore they concluded that low rather than high NO bioavailability contributes to the genesis of experimental cerebral malaria.”
BackgroundHypoarginaemia among Pre- School Children of African Descent with Plasmodium Falciparum Malaria
Erhabor, O. (2017) · Haematology International Journal · doi:10.23880/hij-16000102 · Cited by 1
Saliu, O. A., Akanji, M. A., & Idowu, A. O. (2022) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.1055/s-0042-1758033 · Cited by 2
Experimental Cerebral Malaria Alters Blood Lipid Levels during Pathogenesis
Lv, L., Hai, L., Wang, Q., & Shi, X. (2019) · Journal of Parasitology · doi:10.1645/18-162 · Cited by 2
Gene-knockout mice in malaria research: useful or misleading?
Hernandez-Valladares, M., Naessens, J., & Iraqi, F. A. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.014 · Cited by 3
Role of Nitric oxide synthase II in cognitive impairment due to experimental cerebral malaria
Igreja-Silva, T., Cunha‐Fernandes, T., Moreira, E. T. D. S., Ferreira, A. D. C., Estato, V., Castro-Faria-Neto, H. C., & dos Reis, P. R. P. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.10.002 · Cited by 2
Stins, M. F., Gramaglia, I., Velez, J., Pardo, C. A., & van der Heyde, H. (2025) · Cells · doi:10.3390/cells14110807 · Cited by 1
“At that time the eCM signs were apparent with eCM clinical scores between 4 and 6 were included, similar to our previous publications [50–52 , 57 ].”
Self-citationFreire-Antunes, L., Ornellas-Garcia, U., Rangel-Ferreira, M. V., Ribeiro-Almeida, M. L., Carvalho, L. J. M., Daniel‐Ribeiro, C. T., & Ribeiro-Gomes, F. L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1494418 · Cited by 2
“The iNOS -/- or eNOS -/- animals exhibited parasitemia and ECM development course comparable to that of the control group (69, 70), while administration of exogenous NO protected the animals from ECM (63, 70).”
Intravascular hemolysis aggravates ventilator-induced lung injury in mice
Buttenberg, M., Bünger, V., Taher, M., Höfer, N., Rinderknecht, H., Relja, B., Klopfleisch, R., Francis, R. C. E., Kuebler, W. M., & Graw, J. A. (2026) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2025 · Cited by 1
The Contribution of Vasospasm in the Pathophysiology of Cerebral Malaria
Eisenhut, M. (2012) · Future Microbiology · doi:10.2217/fmb.12.112 · Cited by 1
Tavares, J. C. (2013) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00091ed1v01y201309isp045 · Cited by 1
Dzigba, P. (2013) · Cited by 2
Current Advances in Cerebral Malaria Associated Encephalopathy
Liu, M., Guo, S., Battle, M., & Jonathan, K. (2012) · InTech eBooks · doi:10.5772/30739
Engineered tools for studying the malaria parasite plasmodium falciparum
Wall, B. A. (2015) · DSpace@MIT (Massachusetts Institute of Technology)
Metadata
- Authors
- Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J. P., Frangos, J. A., Intaglietta, M., & van der Heyde, H. C.
- Affiliations
- La Jolla Bioengineering Institute (US)
- Venue
- Nature Medicine
- Published
- 2006-11-12
- Volume
- 12
- Issue
- 12
- Pages
- 1417-1422
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2095371540
- Cited by
- 215
- References
- 31
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 13 · 2013: 20 · 2012: 15
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL040696, HL40696, R24 HL 643952)
- National Institute of Allergy and Infectious Diseases (R01AI040667, AI 40667)
- National Institute of Biomedical Imaging and Bioengineering (EB003824, R01EB003824)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- cerebral malaria, nitric oxide bioavailability, exogenous nitric oxide, malaria, free hemoglobin, nitrite, vascular leakage, petechiae, pro-inflammatory markers, cerebral vasculature, Plasmodium falciparum
- MeSH terms
- Alkenes, Animals, Arginine, Blood Pressure, Capillary Permeability, Cyclic GMP, Hemoglobins, Mice, Inbred C57BL, Models, Biological, Nitric Oxide, Nitrites, Plasmodium berghei, Tissue Distribution, Malaria, Cerebral, Mice, Knockout, Models, Animal, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.